122 related articles for article (PubMed ID: 9473159)
1. Urinary gonadotropin peptide levels in preeclamptic and normotensive pregnant women. Results from a pilot case-control study.
Williams MA; Luthy DA; Zingheim RW; Zebelman AM; Sorensen TK; Resta RG
Gynecol Obstet Invest; 1998; 45(1):24-8. PubMed ID: 9473159
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
Canick JA; Kellner LH; Saller DN; Palomaki GE; Walker RP; Osathanondh R
Prenat Diagn; 1995 Aug; 15(8):739-44. PubMed ID: 7479592
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum nicked and urinary beta-core fragment hCG in preeclamptic pregnancies.
Lee IS; Chung DY; Cole LA; Copel JA; Isozaki T; Hsu CD
Obstet Gynecol; 1997 Dec; 90(6):889-92. PubMed ID: 9397096
[TBL] [Abstract][Full Text] [Related]
4. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
[TBL] [Abstract][Full Text] [Related]
5. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia.
Bahado-Singh RO; Oz U; Isozaki T; Seli E; Kovanci E; Hsu CD; Cole L
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):738-41. PubMed ID: 9757981
[TBL] [Abstract][Full Text] [Related]
6. Urinary gonadotropin peptide: collection of specimens and cutoff levels.
Plebani M; Navaglia F; Bacelle L; Polonio S; Lazzari F; Marchetti M
J Clin Lab Anal; 1995; 9(4):230-3. PubMed ID: 7562239
[TBL] [Abstract][Full Text] [Related]
7. Cross-reaction with luteinizing hormone beta-core is responsible for the age-dependent increase of immunoreactive beta-core fragment of human chorionic gonadotropin in women with nonmalignant conditions.
Iles RK; Javid MK; Gunn LK; Chard T
Clin Chem; 1999 Apr; 45(4):532-8. PubMed ID: 10102914
[TBL] [Abstract][Full Text] [Related]
8. UGP in urogenital disorders: Egyptian experience.
el-Ahmady O; Halim AB; Gad M; Walker R
Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
[TBL] [Abstract][Full Text] [Related]
9. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester maternal urinary gonadotrophin peptide screening for fetal Down syndrome in Asian women.
Lam YH; Tang MH; Tang LC; Lee CP; Ho PK
Prenat Diagn; 1997 Dec; 17(12):1101-6. PubMed ID: 9467806
[TBL] [Abstract][Full Text] [Related]
11. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia.
Hsu CD; Chan DW; Iriye B; Johnson TR; Hong SF; Repke JT
Am J Obstet Gynecol; 1994 Apr; 170(4):1135-8. PubMed ID: 8166197
[TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies.
Kharfi A; Giguère Y; De Grandpré P; Moutquin JM; Forest JC
Clin Biochem; 2005 Aug; 38(8):717-21. PubMed ID: 15904911
[TBL] [Abstract][Full Text] [Related]
14. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
Schwarz-Roeger U; Petzoldt B; Waldschmidt R; Walker RP; Bauknecht T; Kiechle M
Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
[TBL] [Abstract][Full Text] [Related]
15. Urinary gonadotropin peptide as acute phase reactant: transient elevation after operation for digestive diseases.
Motoo Y; Watanabe H; Okai T; Sawabu N
Eur J Endocrinol; 1999 Jun; 140(6):555-60. PubMed ID: 10366410
[TBL] [Abstract][Full Text] [Related]
16. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex.
Steier JA; Ulstein M; Myking OL
Obstet Gynecol; 2002 Sep; 100(3):552-6. PubMed ID: 12220777
[TBL] [Abstract][Full Text] [Related]
18. Urinary gonadotropin peptide in patients with cancer of digestive organs.
Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N
Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740
[TBL] [Abstract][Full Text] [Related]
19. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
20. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
